secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vor Biopharma Inc. (VOR)
CIK:        0001817229
Form:       8-K
Filed at:   2024-06-10T23:59:59+00:00
Accession:  0001193125-24-158320
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Vor Biopharma CFO Nathan Jorgensen resigns; CEO Ang named interim principal financial officer
--------------------------------------------------------------------------------

- Nathan Jorgensen resigns as CFO effective June 21, 2024, to pursue a new opportunity; no disagreement cited.
- CEO Robert Ang appointed interim principal financial officer; VP of Finance Amy Quinlan interim principal accounting officer.
- Company has launched search for a permanent CFO.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1817229/000119312524158320/0001193125-24-158320-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1817229/000119312524158320/d847248d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-158320

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer